SCHEMBL8900353

SCHEMBL8900353

COc1ccc(Nc2nc(Nc3ccc(C(N)C(C)=O)cc3)nc3c(OC)cccc23)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.49
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
NPC1 O15118 2/20 0.44
MERTK Q12866 4/20 0.43
BRD4 O60885 1/20 0.43
GPR139 Q6DWJ6 1/20 0.41
TP53 P04637 3/20 0.40
MAPT P10636 2/20 0.40
POLB P06746 1/20 0.40
BLM P54132 1/20 0.40
GAA P10253 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PIN1 Q13526 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
SLC2A1 P11166 1/20 0.40
CHEK1 O14757 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8900393 0.86 SYK (0.47) MEN1KMT2A
SCHEMBL8889835 0.83 NPY5R (0.43) NPY5RPIN1
SCHEMBL8899460 0.83 NPY5R (0.70) NPY5RMEN1KMT2ANPC1MERTK
SCHEMBL8900365 0.82 SLC2A1 (0.49) NPY5RMEN1KMT2ANPC1MERTK
Hydrochloric Acid SCHEMBL6039207 0.82 NPY5R (0.69) NPY5RMEN1KMT2ANPC1MERTK
Hydrochloric Acid SCHEMBL6039334 0.82 NPY5R (0.69) NPY5RMEN1KMT2ANPC1MERTK
SCHEMBL8893955 0.81 NPY5R (0.40) NPY5RMEN1KMT2APOLBSMN1; SMN2
SCHEMBL8898845 0.77 NPY5R (0.41) NPY5RMEN1KMT2ABRD4POLB
Hydrochloric Acid SCHEMBL8905477 0.76 NPY5R (0.40) NPY5RMEN1KMT2ABRD4POLB
SCHEMBL8900176 0.73 NPY5R (0.53) NPY5RMERTKSLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997020822-A1 QUINAZOLIN-2,4-DIAZIRINES AS NPY RECEPTOR ANTAGONIST NOVARTIS AG (CH) 1997-06-12 WO disclosed